Journal article
The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus
Supportive care in cancer, v 31(12), 672
01 Dec 2023
PMID: 37925388
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Abstract Skin toxicities are very common in patients undergoing cancer treatment and have been found to occur with all types of cancer therapeutic interventions (cytotoxic chemotherapy, targeted therapies, immunotherapy, and radiotherapy). Further, skin toxicities can lead to interruption or even discontinuation of anticancer treatment in some patients, translating to suboptimal outcomes. Dermocosmetics (or cosmeceuticals)—defined as skincare solutions incorporating dermatologically active ingredients (beyond vehicle effects) that directly improve symptoms of various skin conditions—are increasingly being used in cancer care to prevent and manage skin toxicities. The active ingredients in these products have a measurable biological action in skin; they typically improve skin integrity (barrier function/hydration and other factors) while relieving skin symptoms. The Association Francophone des Soins Oncologiques de Support (AFSOS) and Multinational Association of Supportive Care in Cancer (MASCC) partnered to select a multidisciplinary group of healthcare professionals involved in the management of patients with cancer and skin toxicities. The group reviewed existing literature and created a summary of recommendations for managing these toxicities through online meetings and communication. In this publication, the group (1) reviews new skin toxicities seen with oncology drugs and (2) evaluates the role of dermocosmetics in improving patient outcomes and minimizing cancer treatment interruptions. We provide general recommendations for initiation and selection of skin care in all oncology patients as well as recommendations for what factors should be considered when using dermocosmetics in specific types of skin toxicities.
Metrics
1 Record Views
Details
- Title
- The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus
- Creators
- Brigitte Dreno - Immunology and New Concepts in ImmunoTherapyKiarash Khosrotehrani - The University of QueenslandGiselle de Barros Silva - Oswaldo Cruz German Hospital [São Paulo]Julie Ryan Wolf - University of RochesterDelphine Kerob - La Roche-Posay Dermatological Laboratories [Asnières]Mark Trombetta - Drexel UniversityEtienne Atenguena - Université de Yaoundé IPascale Dielenseger - Institut Gustave RoussyMeng Pan - Shanghai Jiao Tong UniversityFlorian Scotte - Institut Gustave RoussyIvan Krakowski - Medical Oncologist [Bordeaux]Mario Lacouture - Memorial Sloan Kettering Cancer Center
- Publication Details
- Supportive care in cancer, v 31(12), 672
- Publisher
- Springer Nature
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Radiology (Radiologic Sciences)
- Web of Science ID
- WOS:001095490100003
- Scopus ID
- 2-s2.0-85175872436
- Other Identifier
- 991022207158404721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
Source: SDGs in the Output
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- International collaboration
- Web of Science research areas
- Health Care Sciences & Services
- Oncology
- Rehabilitation